ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,435, issued on Dec. 30, was assigned to UNM RAINFOREST INNOVATIONS (Albuquerque, N.M.) and ARROWHEAD CENTER INC (Las Cruces, N.M.).
"Compounds for selective binding to estrogen receptors alpha/beta relative to GPER/GPR30 and methods of treating disease states and conditions mediated through these receptors" was invented by Eric R. Prossnitz (Albuquerque, N.M.), Jeffrey B. Arterburn (Las Cruces, N.M.) and Cristian Bologa (Albuquerque, N.M.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention is in the field of molecular biology/pharmacology and provides novel 3-oxabicyclo[3.3.1]nonene compounds and derivatives that modulate the effect...